Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Affordable Medications Act This bill revises and expands various requirements relating to prescription drug pricing and affordability. Specifically, the bill expands financial reporting requirements for drug manufacturers and establishes corresponding civil penalties for noncompliance; it also adds reporting requirements for certain nonprofit patient-assistance programs. Further, the bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate prices for certain prescription drugs under Medicare and requires the Centers for Medicare and Medicaid Innovation within the CMS to test specified models for negotiating drug prices. It also establishes reporting requirements, and corresponding civil penalties for noncompliance, for pharmaceutical companies with respect to spikes in prescription drug prices. The bill establishes an excise tax on prescription drugs subject to price spikes, lessens prescription drug cost-sharing requirements under qualified health plans and group health plans, and modifies requirements for the importation of prescription drugs. It also requires drug manufacturers to provide rebates for drugs dispensed to certain low-income individuals under the Medicare program and limits the time frame that trade agreements are required to provide market exclusivity for biological products. Additionally, the bill (1) requires the Food and Drug Administration to establish a database of generic drugs; (2) modifies other provisions related to generic drugs, prescription drug advertising, disclosure of wholesale acquisition prices, and patent-infringement proceedings; and (3) revises certain time frames and conditions related to drug exclusivity. Finally, it establishes an innovation incentive fund for new or more effective treatments of bacterial infections and establishes the Center for Clinical Research within the National Institutes of Health.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2022 · fourth_quarter · Advertising
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Issues relating to the deductibility of advertising as an ordinary business expense. Issues relating to advertising by cannabis businesses on broadcast stations in states where cannabis is legal. Issues relating to direct to consumer advertising. Issues relating to the federal government purchasing advertising on broadcast stations. Issues relating to the creation of a reinsurance program for businesses affected by pandemics. Issues relating to jurisdiction and treatment of broadcast advertising. H.R. 1, For the People Act of 2021, Provisions relating to radio and television advertising. H.R. 1171, Stand By Every Ad Act, Provisions relating to broadcaster advertising. H.R. 1334, DISCLOSE Act of 2021Provisions relating to radio and television advertising. H.R. 5823, Pandemic Risk Insurance Act of 2021, All provisions. H.R. 5897, Fair and Clear Campaign Transparency Act, All provisions. H.R. 5997, Crack Down on Dark Money Act, Provisions relating to radio and television advertising. H.R. 6392, No Tax Breaks for Drug Ads Act, All provisions. H.R. 7703, Commercial Advertisement Loudness Mitigation Modernization Act of 2022, Provisions relating to radio and television advertising. H.R. 7776, James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, Provisions relating to the federal government purchasing advertising on broadcast stations. H.R. 7900, National Defense Authorization Act for Fiscal Year 2023, Provisions relating to the federal government purchasing advertising on broadcast stations. H.R. 8152, American Data Privacy and Protection Act, Provisions relating to jurisdiction and treatment of broadcast advertising. H.R. 8289, Banning Misleading Drug Ads Act of 2022, Provisions relating to radio and television advertising. H.R. 8737, End Subsidies for Fossil Fuel Advertising Act, Provisions relating to the deductibility of advertising as an ordinary business expense. H.R. 9299, Stop Subsidizing Childhood Obesity Act, All provisions. S. 141, End Taxpayer Subsidies for Drug Ads Act, All provisions. S. 436, American Broadband Buildout Act of 2021, Provisions relating to public awareness campaigns. S.1898, Affordable Medications Act, Provisions relating to the deductibility of advertising as an ordinary business expense. S. 2016, Surface Transportation Investment Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. S. 2152, Fair and Clear Campaign Transparency Act, All provisions. S. 4173, Commercial Advertisement Loudness Mitigation Modernization Act of 2022, Provisions relating to radio and television advertising. S. 4543, James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, Provisions relating to the federal government purchasing advertising on broadcast stations. S. 4591, Cannabis Administration and Opportunity Act, Provisions relating to radio and television advertising. S. 4622, Secure And Fair Enforcement Advertising Act of 2022, Provisions relating to radio and television advertising. S. 4788, Go Pack Go Act of 2022,All provisions. S. 4822, DISCLOSE Act of 2022, Provisions relating to radio and television advertising. S. 5054, Honest Ads Act, All provisions. S. 5086, Stop Subsidizing Childhood Obesity Act, All provisions. S. 5213, No Tax Subsidies for E-Cigarette and Tobacco Ads Act, All provisions.
Client expense: $2,880,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Advertising
Issues relating to the deductibility of advertising as an ordinary business expense. Issues relating to advertising by cannabis businesses on broadcast stations in states where cannabis is legal. Issues relating to direct to consumer advertising. Issues relating to the federal government purchasing advertising on broadcast stations. Issues related to the creation of a reinsurance program for businesses affected by pandemics. Issues relating to jurisdiction and treatment of broadcast advertising. H.R. 1, For the People Act of 2021, Provisions relating to radio and television advertising. H.R. 1171, Stand By Every Ad Act, Provisions relating to broadcaster advertising. H.R. 1334, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. H.R. 5823, Pandemic Risk Insurance Act of 2021, All provisions. H.R. 5897, Fair and Clear Campaign Transparency Act, All provisions. H.R. 5997, Crack Down on Dark Money Act, Provisions relating to radio and television advertising. H.R. 6392, No Tax Breaks for Drug Ads Act, All provisions. H.R. 7703, Commercial Advertisement Loudness Mitigation Modernization Act of 2022, Provisions relating to radio and television advertising. H.R. 7900, National Defense Authorization Act for Fiscal Year 2023, Provisions relating to the federal government purchasing advertising on broadcast stations. H.R. 8152, American Data Privacy and Protection Act, Provisions relating to jurisdiction and treatment of broadcast advertising. H.R. 8289, Banning Misleading Drug Ads Act of 2022, Provisions relating to radio and television advertising. H.R. 8737, End Subsidies for Fossil Fuel Advertising Act, Provisions relating to the deductibility of advertising as an ordinary business expense. S. 141, End Taxpayer Subsidies for Drug Ads Act, All provisions S. 436, American Broadband Buildout Act of 2021, Provisions related to public awareness campaigns. S.1898, Affordable Medications Act, Provisions relating to the deductibility of advertising as an ordinary business expense. S. 2016, Surface Transportation Investment Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. S. 2152, Fair and Clear Campaign Transparency Act, All provisions. S. 4173, Commercial Advertisement Loudness Mitigation Modernization Act of 2022, Provisions relating to radio and television advertising. S. 4543, James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, Provisions relating to the federal government purchasing advertising on broadcast stations. S. 4591, Cannabis Administration and Opportunity Act, Provisions relating to radio and television advertising. S. 4622, Secure And Fair Enforcement Advertising Act of 2022, Provisions relating to radio and television advertising. S. 4788, Go Pack Go Act of 2022, All provisions. S. 4822, DISCLOSE Act of 2022, Provisions relating to radio and television advertising.
Client expense: $2,830,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: Not reported · Firm income: $10,000
2022 · second_quarter · Advertising
Issues relating to the deductibility of advertising as an ordinary business expense. Issues relating to advertising by cannabis businesses on broadcast stations in states where cannabis is legal. Issues relating to direct to consumer advertising. Issues relating to the federal government purchasing advertising on broadcast stations. Issues related to the creation of a reinsurance program for businesses effected by pandemics. Issues related to jurisdiction and treatment of broadcast advertising. H.R. 1, For the People Act of 2021, Provisions relating to radio and television advertising. H.R. 1171, Stand By Every Ad Act, Provisions relating to broadcaster advertising. H.R. 1334, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. H.R. 5823, Pandemic Risk Insurance Act of 2021. H.R. 5897, Fair and Clear Campaign Transparency Act. H.R. 5997, Crack Down on Dark Money Act, Provisions relating to radio and television advertising. S. 141, End Taxpayer Subsidies for Drug Ads Act, All provisions S. 436, American Broadband Buildout Act of 2021, Provisions related to public awareness campaigns. S. 443, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. S.1898, Provisions relating to the deductibility of advertising as an ordinary business expense. S. 2016, Provisions relating to the federal government purchasing advertising on broadcast stations. S. 2152, Fair and Clear Campaign Transparency Act. S.2792, National Defense Authorization Act for Fiscal Year 2022, Provisions relating to the federal government purchasing advertising on broadcast stations. H.R. 6392, No Tax Breaks for Drug Ads Act, All provisions. H.R. 7703, Commercial Advertisement Loudness Mitigation Modernization Act of 2022, Provisions relating to radio and television advertising. H.R. 8152, American Data Privacy and Protection Act, Provisions relating to jurisdiction and treatment of broadcast advertising. S. 4173, Commercial Advertisement Loudness Mitigation Modernization Act of 2022, Provisions relating to radio and television advertising.
Client expense: $2,680,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Advertising
Issues relating to the deductibility of advertising as an ordinary business expense. Issues relating to advertising by cannabis businesses on broadcast stations in states where cannabis is legal. Issues relating to direct to consumer advertising. Issues relating to the federal government purchasing advertising on broadcast stations. Issues related to the creation of a reinsurance program for businesses effected by pandemics. H.R. 1, For the People Act of 2021, Provisions relating to radio and television advertising. H.R. 1171, Stand By Every Ad Act, Provisions relating to broadcaster advertising. H.R. 1334, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. H.R. 5823, Pandemic Risk Insurance Act of 2021. H.R. 5897, Fair and Clear Campaign Transparency Act. H.R. 5997, Crack Down on Dark Money Act, Provisions relating to radio and television advertising. S. 141, End Taxpayer Subsidies for Drug Ads Act, All provisions S. 436, American Broadband Buildout Act of 2021, Provisions related to public awareness campaigns. S. 443, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. S.1898, Provisions relating to the deductibility of advertising as an ordinary business expense. S. 2016, Provisions relating to the federal government purchasing advertising on broadcast stations. S. 2152, Fair and Clear Campaign Transparency Act. S.2792, National Defense Authorization Act for Fiscal Year 2022, Provisions relating to the federal government purchasing advertising on broadcast stations. H.R. 6392, No Tax Breaks for Drug Ads Act, All provisions.
Client expense: $2,550,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: Not reported · Firm income: $30,000
2021 · third_quarter · Advertising
Issues relating to the deductibility of advertising as an ordinary business expense. Issues relating to direct to consumer advertising. Issues relating to the federal government purchasing advertising on broadcast stations. Issues related to the creation of a reinsurance program for businesses effected by pandemics. Issues relating to federal funding for local journalism. Issues relating to advertising by cannabis businesses on broadcast stations in states where cannabis is legal. Issues relating to federal funding for local journalism. H.R. 1, For the People Act of 2021, Provisions relating to radio and television advertising. H.R. 1171, Stand By Every Ad Act, Provisions relating to broadcaster advertising. H.R. 1334, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. H.R. 1400, COVID-19 Health Disparities Action Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. S. 141, End Taxpayer Subsidies for Drug Ads Act, All provisions S. 436, American Broadband Buildout Act of 2021, Provisions related to public awareness campaigns. S. 443, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. S. 465, COVID-19 Health Disparities Action Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. S.1898, Provisions relating to the deductibility of advertising as an ordinary business expense. S. 2016, Provisions relating to the federal government purchasing advertising on broadcast stations. S.2792, National Defense Authorization Act for Fiscal Year 2022, Provisions relating to the federal government purchasing advertising on broadcast stations.
Client expense: $2,030,000 · Firm income: Not reported
2021 · second_quarter · Advertising
Issues relating to the deductibility of advertising as an ordinary business expense. Issues relating to direct to consumer advertising. Issues relating to the federal government purchasing advertising on broadcast stations. Issues related to the creation of a reinsurance program for businesses effected by pandemics. Issues relating to federal funding for local journalism. Issues relating to advertising by cannabis businesses on broadcast stations in states where cannabis is legal. Issues relating to federal funding for local journalism. H.R. 1, For the People Act of 2021, Provisions relating to radio and television advertising. H.R. 1171, Stand By Every Ad Act, Provisions relating to broadcaster advertising. H.R. 1334, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. H.R. 1400, COVID-19 Health Disparities Action Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. S. 141, End Taxpayer Subsidies for Drug Ads Act, All provisions S. 436, American Broadband Buildout Act of 2021, Provisions related to public awareness campaigns. S. 443, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. S. 465, COVID-19 Health Disparities Action Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. S.1898, Provisions relating to the deductibility of advertising as an ordinary business expense. S. 2016, Provisions relating to the federal government purchasing advertising on broadcast stations.
Client expense: $2,180,000 · Firm income: Not reported
2021 · fourth_quarter · Health Issues
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 5801 (HELP Copays Act), all provisions
Client expense: Not reported · Firm income: $30,000
2021 · fourth_quarter · Advertising
Issues relating to the deductibility of advertising as an ordinary business expense. Issues relating to advertising by cannabis businesses on broadcast stations in states where cannabis is legal. Issues relating to direct to consumer advertising. Issues relating to the federal government purchasing advertising on broadcast stations. Issues related to the creation of a reinsurance program for businesses effected by pandemics. H.R. 1, For the People Act of 2021, Provisions relating to radio and television advertising. H.R. 1171, Stand By Every Ad Act, Provisions relating to broadcaster advertising. H.R. 1334, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. H.R. 1400, COVID-19 Health Disparities Action Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. H.R. 5823, Pandemic Risk Insurance Act of 2021. H.R. 5897, Fair and Clear Campaign Transparency Act. H.R. 5997, Crack Down on Dark Money Act, Provisions relating to radio and television advertising. S. 141, End Taxpayer Subsidies for Drug Ads Act, All provisions S. 436, American Broadband Buildout Act of 2021, Provisions related to public awareness campaigns. S. 443, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. S. 465, COVID-19 Health Disparities Action Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. S.1898, Provisions relating to the deductibility of advertising as an ordinary business expense. S. 2016, Provisions relating to the federal government purchasing advertising on broadcast stations. S. 2152, Fair and Clear Campaign Transparency Act. S.2792, National Defense Authorization Act for Fiscal Year 2022, Provisions relating to the federal government purchasing advertising on broadcast stations.
2021 · third_quarter · Health Issues
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Medicare/Medicaid
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act - Provisions related to prescription drug pricing, non-interference, and intellectual property H.R. 19: Lower Costs, More Cures Act of 2021 - Provisions related to prescription drugs H.R. 550: Immunization Infrastructure Modernization Act H.R.3684 - Infrastructure Investment and Jobs Act - provisions related to vial size wastage policy H.R.5260 - Reduced Costs and Continued Cures Act H.R. 7614: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021 H.R. 7616: Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 H.R. 4100/S. 1712: DISARM Act of 2019 a Provisions related to antimicrobial drug development H.R. 6222: Ensuring Affordable COVID-19 Preventive Care Act of 2020 Provisions related to prescription drug pricing and access H.R. 1227: Medicare-X Choice Act of 2021 - Provisions related to Part D and non-interference H.R. 1976: Medicare for All Act of 2021 - Provisions related to Part D and non-interference H.R. 2010: Public Option Deficit Reduction Act - Provisions related to Part D and non-interference H.R. 2071: Medicare Prescription Drug Price Negotiation Act of 2021 - Provisions related to Part D and non-interference H.R. 2139: Medicare Drug Price Negotiation Act - Provisions related to Part D and non-interference H.R. 5260: Reduced Costs and Continued Cures Act - Provisions related to prescription drug pricing and access H.R. 5463: Drug Pricing Transparency and Accountability Act - To increase reporting requirements and transparency requirements in the 340B Drug Pricing Program, and for other purposes S. 386: Medicare-X Choice Act of 2021 - Provisions related to Part D and non-interference S. 833: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021 - Provisions related to Part D and non-interference S. 908: Medicare Drug Price Negotiation Act - Provisions related to prescription drug pricing and non-interference S. 983: CHOICE Act - Provisions related to Part D and non-interference S. 1619/H.R. 2862: VACCINES Act S. 1872/H.R. 5075: Protecting Seniors Through Immunization Act S. 2304: Strategies To Address Antibiotic Resistance Act a Provisions related to antimicrobial resistance (AMR) and other issues S. 4320: Coronavirus Response Additional Supplemental Appropriations Act, 2020 S. 4760/H.R. 8920: PASTEUR Act (AMR) S. 4864/H.R. 8725: HAP Act; Medicaid financial barriers S. 1123: PING Act - Provisions related to Part D and non-interference S. 1287: REFUND Act of 2021 - Provisions related to Part B and vial sizes S. 1773: Prescription Drug Pricing Dashboard Act - Provisions related to Medicare, Medicaid and prescription drug pricing transparency S. 1898: Affordable Medications Act - Provisions related to prescription drug pricing, Part D, non-interference, Part B, and intellectual property S. 2164: Lower Costs, More Cures Act - Provisions related to prescription drug pricing and access S. 2327: Seniors Prescription Drug Relief Act - Provisions related to Part D, prescription drug access and pricing Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues VA drug pricing policy issues Transparency policy issues Alternative payment models policy issues Value-based purchasing arrangements policy issues Anti-Kickback Statute policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues Medicaid rebates and waiver policy issues Medicare prescription drug payments cards and related policy issues ___ Tenncare III 1115 Medicaid Demonstration - regarding closed formulary Final Rule; Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021; Notice Requirement for Non-Federal Governmental Plans Final Rule; Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2022; Updates to State Innovation Waiver (Section 1332 Waiver) Implementing Regulations Final Rule; Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
2021 · third_quarter · Advertising
Issues relating to the deductibility of advertising as an ordinary business expense. Issues relating to direct to consumer advertising. Issues relating to the federal government purchasing advertising on broadcast stations. Issues related to the creation of a reinsurance program for businesses effected by pandemics. Issues relating to federal funding for local journalism. Issues relating to advertising by cannabis businesses on broadcast stations in states where cannabis is legal. Issues relating to federal funding for local journalism. H.R. 1, For the People Act of 2021, Provisions relating to radio and television advertising. H.R. 1171, Stand By Every Ad Act, Provisions relating to broadcaster advertising. H.R. 1334, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. H.R. 1400, COVID-19 Health Disparities Action Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. S. 141, End Taxpayer Subsidies for Drug Ads Act, All provisions S. 436, American Broadband Buildout Act of 2021, Provisions related to public awareness campaigns. S. 443, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. S. 465, COVID-19 Health Disparities Action Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. S.1898, Provisions relating to the deductibility of advertising as an ordinary business expense. S. 2016, Provisions relating to the federal government purchasing advertising on broadcast stations. S.2792, National Defense Authorization Act for Fiscal Year 2022, Provisions relating to the federal government purchasing advertising on broadcast stations.
Client expense: $2,030,000 · Firm income: Not reported
2021 · third_quarter · Medicare/Medicaid
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act - Provisions related to prescription drug pricing, non-interference, and intellectual property H.R. 19: Lower Costs, More Cures Act of 2021 - Provisions related to prescription drugs H.R. 1227: Medicare-X Choice Act of 2021 - Provisions related to Part D and non-interference H.R. 1976: Medicare for All Act of 2021 - Provisions related to Part D and non-interference H.R. 2010: Public Option Deficit Reduction Act - Provisions related to Part D and non-interference H.R. 2071: Medicare Prescription Drug Price Negotiation Act of 2021 - Provisions related to Part D and non-interference H.R. 2139: Medicare Drug Price Negotiation Act - Provisions related to Part D and non-interference H.R. 5260: Reduced Costs and Continued Cures Act - Provisions related to prescription drug pricing and access H.R. 5463: Drug Pricing Transparency and Accountability Act - To increase reporting requirements and transparency requirements in the 340B Drug Pricing Program, and for other purposes S. 386: Medicare-X Choice Act of 2021 - Provisions related to Part D and non-interference S. 833: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021 - Provisions related to Part D and non-interference S. 908: Medicare Drug Price Negotiation Act - Provisions related to prescription drug pricing and non-interference S. 983: CHOICE Act - Provisions related to Part D and non-interference S. 1123: PING Act - Provisions related to Part D and non-interference S. 1287: REFUND Act of 2021 - Provisions related to Part B and vial sizes S. 1773: Prescription Drug Pricing Dashboard Act - Provisions related to Medicare, Medicaid and prescription drug pricing transparency S. 1898: Affordable Medications Act - Provisions related to prescription drug pricing, Part D, non-interference, Part B, and intellectual property S. 2164: Lower Costs, More Cures Act - Provisions related to prescription drug pricing and access S. 2327: Seniors Prescription Drug Relief Act - Provisions related to Part D, prescription drug access and pricing S. 2815: Seniors Saving on Insulin Act - Provisions related to Part D and insulin pricing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues VA drug pricing policy issues Transparency policy issues Alternative payment models policy issues Value-based purchasing arrangements policy issues Anti-Kickback Statute policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues Medicaid rebates and waiver policy issues Medicare prescription drug payments cards and related policy issues Tenncare III 1115 Medicaid Demonstration - regarding closed formulary Final Rule; Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021; Notice Requirement for Non-Federal Governmental Plans Final Rule; Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2022; Updates to State Innovation Waiver (Section 1332 Waiver) Implementing Regulations Final Rule; Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
2021 · second_quarter · Health Issues
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Advertising
Issues relating to the deductibility of advertising as an ordinary business expense. Issues relating to direct to consumer advertising. Issues relating to the federal government purchasing advertising on broadcast stations. Issues related to the creation of a reinsurance program for businesses effected by pandemics. Issues relating to federal funding for local journalism. Issues relating to advertising by cannabis businesses on broadcast stations in states where cannabis is legal. Issues relating to federal funding for local journalism. H.R. 1, For the People Act of 2021, Provisions relating to radio and television advertising. H.R. 1171, Stand By Every Ad Act, Provisions relating to broadcaster advertising. H.R. 1334, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. H.R. 1400, COVID-19 Health Disparities Action Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. S. 141, End Taxpayer Subsidies for Drug Ads Act, All provisions S. 436, American Broadband Buildout Act of 2021, Provisions related to public awareness campaigns. S. 443, DISCLOSE Act of 2021, Provisions relating to radio and television advertising. S. 465, COVID-19 Health Disparities Action Act of 2021, Provisions relating to the federal government purchasing advertising on broadcast stations. S.1898, Provisions relating to the deductibility of advertising as an ordinary business expense. S. 2016, Provisions relating to the federal government purchasing advertising on broadcast stations.
Client expense: $2,180,000 · Firm income: Not reported
2021 · second_quarter · Pharmacy
S.833 - Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021 - in support. S. 415 - Ensuring Innovation Act - in support. S. 1323. End Price Gouging for Medications Act - in support. H.R. 2829. End Price Gouging for Medications Act - in support. H.R. 3. Lower Drug Costs Now Act - in support. S. 1898. Affordable Medications Act - in support. Lobbied in support of including drug pricing reforms in the reconciliation bill. Lobbied in support of a temporary waiver of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement for the COVID-19 vaccine.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
| Democratic |
| MA |
| Jack Reed | Democratic | RI |
| Jeff Merkley | Democratic | OR |
| Kirsten E. Gillibrand | Democratic | NY |
| Margaret Wood Hassan | Democratic | NH |
| Richard Blumenthal | Democratic | CT |
| Richard J. Durbin | Democratic | IL |
| Sheldon Whitehouse | Democratic | RI |
| Sherrod Brown | Democratic | OH |
| Tammy Baldwin | Democratic | WI |
| HR 7828 |
117th |
| Related bill |
| HR 6392 | 117th | Related bill |
| HR 2181 | 117th | Related bill |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $1,960,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $1,200,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $7,440,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE